U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07408713) titled 'Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function' on Feb. 06.
Brief Summary: Hematopoietic stem cell transplantation (HSCT) is a potentially life-saving treatment for children with relapsed or resistant leukemia and other life-threatening hematological and hereditary disorders. In Denmark, around 25 children undergo allogeneic HSCT every year, of these approximately 85-90% survive into adulthood.
The goal of this observational study is to learn about neurocognitive outcomes in children undergoing (HSCT) and to understand which clinical, physical, and environmental ...